Articles

Expression of COBLL1 encoding novel ROR1 binding partner is robust predictor of survival in chronic lymphocytic leukemia

Center of Molecular Biology and Gene Therapy, Department of Internal Medicine– Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic;Central European Institute of Technology, Masaryk University, Brno, Czech Republic
Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic;Department of Cytokinetics, Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic
Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic
Center of Molecular Biology and Gene Therapy, Department of Internal Medicine– Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic;Central European Institute of Technology, Masaryk University, Brno, Czech Republic
Generi Biotech, s.r.o., Hradec Králové, Brno, Czech Republic
Center of Molecular Biology and Gene Therapy, Department of Internal Medicine– Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic;Central European Institute of Technology, Masaryk University, Brno, Czech Republic
Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic
Central European Institute of Technology, Masaryk University, Brno, Czech Republic
Center of Molecular Biology and Gene Therapy, Department of Internal Medicine– Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic;Central European Institute of Technology, Masaryk University, Brno, Czech Republic
Center of Molecular Biology and Gene Therapy, Department of Internal Medicine– Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic;Central European Institute of Technology, Masaryk University, Brno, Czech Republic
Center of Molecular Biology and Gene Therapy, Department of Internal Medicine– Hematology and Oncology, University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic;Central European Institute of Technology, Masaryk University, Brno, Czech Republic
Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic;Department of Cytokinetics, Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czech Republic
Vol. 103 No. 2 (2018): February, 2018 https://doi.org/10.3324/haematol.2017.178699